Risk Factors for Mortality in Patients With Hereditary Transthyretin-Mediated Amyloidosis: An Analysis of APOLLO and Global Open Label Extension Studies

Journal of Cardiac Failure - United States
doi 10.1016/j.cardfail.2019.07.276
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Correction To: Analysis of Autonomic Outcomes in APOLLO, a Phase III Trial of the RNAi Therapeutic Patisiran in Patients With Hereditary Transthyretin-Mediated Amyloidosis

Journal of Neurology
Neurology
2020English

Cardiac Findings and Events Observed in an Open-Label Clinical Trial of Tafamidis in Patients With Non-Val30Met and Non-Val122Ile Hereditary Transthyretin Amyloidosis

Journal of Cardiovascular Translational Research
GeneticsPharmaceutical ScienceCardiovascular MedicineMolecular MedicineCardiology
2015English

Impact of Patisiran, an RNAi Therapeutic, on Orthostatic Intolerance in Patients With Hereditary Transthyretin-Mediated Amyloidosis

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Pharmacokinetics of Patisiran, the First Approved RNA Interference Therapy in Patients With Hereditary Transthyretin‐Mediated Amyloidosis

Journal of Clinical Pharmacology
Pharmacology
2019English

Identifying Mixed Phenotype: Evaluating the Presence of Polyneuropathy in Patients With Hereditary Transthyretin-Mediated Amyloidosis With Cardiomyopathy

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

The V122I Mutation in Hereditary Transthyretin-Mediated Amyloidosis Is Significantly Associated With Polyneuropathy

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Alnylam Act®: Heterogenous Disease Manifestations of Hereditary Transthyretin-Mediated Amyloidosis

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Assessment of Patients With Hereditary Transthyretin Amyloidosis – Understanding the Impact of Management and Disease Progression

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Internal MedicineMedicine
2019English

Diagnostic Challenges in Hereditary Transthyretin Amyloidosis With Polyneuropathy: Avoiding Misdiagnosis of a Treatable Hereditary Neuropathy

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy